| 1 |
Pirozzolo G, Cona C, Rizzo M, et al. Long term recurrence in primary liver neuroendocrine tumor: Report of a single case and review of literature [J]. Ann Hepatobiliary Pancreat Surg, 2018, 22(2): 159-163.
|
| 2 |
Akahori T, Sho M, Tanaka T, et al. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors [J]. Anticancer Res, 2013, 33(8): 3355-3358.
|
| 3 |
Chen RW, Qiu MJ, Chen Y, et al. Analysis of the clinicopathological features and prognostic factors of primary hepatic neuroendocrine tumors [J]. Oncol Lett, 2018, 15(6): 8604-8610.
|
| 4 |
Li R, Tang CL, Yang D, et al. Primary hepatic neuroendocrine tumors: clinical characteristics and imaging features on contrast-enhanced ultrasound and computed tomography [J]. Abdom Radiol (NY), 2016, 41(9): 1767-1775.
|
| 5 |
Sheng R, Xie Y, Zeng M, et al. MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm:a comparative study [J]. Radiol Med, 2015, 120 (11): 1012-1020.
|
| 6 |
Koukouraki S, Strauss LG, Georgoulias V, et al. Comparison of the pharmacokinetics of 68Ga-DOTATOC and 18F FDG in patients with metastatic neuroendocrine tumors scheduled for 90Y-DOTATOC therapy [J]. Eur J Nucl Med Mol Imaging, 2006, 33(10): 1115-1122.
|
| 7 |
Etchebehere EC, Deoliveira Santos A, Gumz B, et al. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial [J]. J Nucl Med, 2014, 55(10): 1598-1604.
|
| 8 |
Gorla AK, Basher K, Kaman L, et al. 68Ga-DOTATATE PET/CT in primary hepatic neuroendocrine tumor [J]. Clin Nucl Med, 2017, 42(2): 118-120.
|
| 9 |
Torrisi C, Picone D, Cabibbo G, et al. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: another cause of hypointense observation on hepatobiliary phase [J]. Eur J Radiol, 2018, 107: 39-45.
|
| 10 |
Kaya G, Pasche C, Osterheld MC, et al. Primary neuroendo-crine carcinoma of the liver: an autopsy case [J]. Pathol Int, 2001, 51(11): 874-878.
|
| 11 |
Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system [M]. Lyon: IARC Press, 2010: 978-992.
|
| 12 |
Fraenkel M, Faggiano A, Valk GD. Epidemiology of neuroendocrine tumors [J]. Front Horm Res, 2015, 44: 1-23.
|
| 13 |
Huang YQ, Xu F. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases [J]. Hepatobiliary Pancrea Dis Int, 2010, 9(1): 44-48.
|
| 14 |
Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) [J]. Gut, 2012, 61(1): 6-32.
|
| 15 |
Gurung A, Yoshida EM, Scudamore CH, et al. Primary hepatic neuroendocrine tumour requiring live donor liver transplantation: case report and concise review [J]. Ann Hepatol, 2012, 11(5): 715-720.
|
| 16 |
Fenwick SW, Wyatt JI, Toogood GJ, et al. Hepatic resection and transplantation for primary carcinoid tumors of the liver [J]. Ann Surg, 2004, 239(2): 210-219.
|
| 17 |
Lin CW, Lai CH, Hsu CC, et al. Primary hepatic carcinoidtumor: a case report and review of the literature [J]. Cases J, 2009, 2(1): 90.
|